ZW27941: A novel therapeutic strategy for acute myeloid leukemia
Peer-Reviewed Publication
Updates every hour. Last Updated: 12-Jul-2025 17:10 ET (12-Jul-2025 21:10 GMT/UTC)
Acute myeloid leukemia (AML) is an aggressive blood cancer characterized by the uncontrolled proliferation of malignant hematopoietic stem and progenitor cells. METTL3, a key catalytic component within the m6A methyltransferase complex (alongside METTL14), is overexpressed in AML cells and plays a crucial role in promoting cancer. However, effective pharmacological targeting of the RNA m6A transferase core complex remains a challenge.
Background: Percutaneous lung biopsy (PLB) is currently widely utilized in the diagnosis and treatment of lung tumors, owing to its advantages of minimal trauma, high detection rate, and precise localization. However, traditional computed tomography (CT)-guided freehand PLB procedures often involve multiple puncture adjustments and a relatively high incidence of complications. The aim of this study is to investigate whether laser-guided technology can effectively reduce the operative time and incidence of complications.
Methods: This study included 141 patients who underwent CT-guided PLB at the First Affiliated Hospital of Soochow University between January 2022 and January 2024. These patients were divided into two groups based on the use of laser-guided technology during the procedure: the laser-guided group (47 patients) and the manual group (94 patients). Clinical data from all patients were collected. Information such as the success rate of biopsy procedures and the incidence of complications was analyzed and compared.
Results: The procedure time in the laser-guided group was shorter than that in the manual group (P=0.008). In the laser-guided group, the number of adjustments needed to reach the tumor during the positioning step was less than the manual group (P=0.001). In the laser-guided group, the number of CT scans performed before reaching the tumor was smaller than in the manual group (P=0.01). The distance from the first puncture to the lung tumor in the laser-guided group was closer than that in the manual group (P=0.049). The laser-guided group had a smaller angular deviation from the target at the first puncture than the manual group (P=0.004).
Conclusions: Laser-guided technology has the advantages of shorter operation time and less adjustment of biopsy needles. However, laser-guided technology does not reduce the complication rate of biopsy surgery or the length of hospital stay after surgery and there is no statistical difference in the accuracy of pathological diagnoses obtained by the two methods.
Keywords: Laser-guided technology; percutaneous lung biopsy (PLB); lung cancer; pulmonary nodules
Investigators of the Vall d’Hebron Institute of Oncology’s (VHIO) Radiomics Group, led by Raquel Perez-Lopez, have developed SALSA (System for Automatic Liver tumor Segmentation And detection), a fully automated deep learning-driven tool for the precise and completely automated detection and monitoring of liver tumors (hepatocellular carcinoma). Results of this work have been published as an open access article in Cell Reports Medicine.
A recent study published in Medcomm-Oncology highlights the pivotal role of the enzyme alcohol dehydrogenase 4 (ADH4) in suppressing hepatocellular carcinoma (HCC) progression. This inhibition is achieved through the facilitation of retinoic acid (RA) production and the disruption of Wnt/β-cantenin pathway. The researchers further demonstrated that the combination of RA with cisplatin markedly attenuates tumor growth in mouse models, presenting a promising therapeutic strategy for advanced HCC.
A new telemedicine service for personalised breast cancer prevention has launched at preventcancer.co.uk. It allows women aged 30 to 75 across the UK to understand their risk of developing breast cancer and take early action years before NHS screening begins.